Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor illudin analogues synthesized at U. of California

Sep. 15, 1999

Depsipeptide tested in vitro for B-cell CLL inhibition

Sep. 15, 1999

Cell Pathways continues to investigate apoptosis-promoting compounds for neoplastic diseases

Sep. 14, 1999

MS-275: new benzamide inhibitor of histone deacetylase selected as development candidate

Sep. 14, 1999

Phase II trial expanded for Aronex's renal cell carcinoma product

Sep. 13, 1999

U.S. and Canadian academics design novel prodrug approach to 5-FU chemotherapy

Sep. 10, 1999

Roche to submit sNDA for Xeloda as first-line colorectal cancer therapy

Sep. 10, 1999

Israeli group designs new family of nonpeptide, nonsulfhydryl Ras farnesylation inhibitors

Sep. 9, 1999

Atairgin and Washington State University to develop new therapeutic applications

Sep. 9, 1999

Roberts to market Fareston in the U.S.

Sep. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...